TrialMed (New York, N.Y.)2025

BilT03: Phase 1b/2 multicenter trial of nivolumab with 5-fluorouracil and liposomal irinotecan for previously treated advanced biliary tract cancer.

Vaibhav Sahai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.